U.S. Court of Appeals for the Federal Circuit, 2026

Taiho Pharmaceutical Co., Ltd. v. Msn Laboratories Private Ltd.

Taiho Pharmaceutical Co., Ltd. v. Msn Laboratories Private Ltd.
U.S. Court of Appeals for the Federal Circuit · Decided April 28, 2026
Taiho Pharmaceutical Co., Ltd. v. Msn Laboratories Private Ltd.

Opinion

Case: 25-1407 Document: 39 Page: 1 Filed: 04/28/2026

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ TAIHO PHARMACEUTICAL CO., LTD., TAIHO ONCOLOGY, INC., Plaintiffs-Appellants v. MSN LABORATORIES PRIVATE LTD., MSN PHARMACEUTICALS, INC., Defendants-Cross-Appellants ______________________ 2025-1407, 2025-1453 ______________________ Appeals from the United States District Court for the District of Delaware in No. 1:19-cv-02342-JLH, Judge Jen- nifer L. Hall. ______________________ ORDER The parties submit a joint stipulation to voluntarily dismiss the above-captioned appeals with prejudice pursu- ant to Federal Rule of Appellate Procedure 42(b), with each side to bear its own costs.

This court generally does not specify whether a dismis- sal of a matter is with or without prejudice.

Upon consideration thereof, IT IS ORDERED THAT: Case: 25-1407 Document: 39 Page: 2 Filed: 04/28/2026

2 TAIHO PHARMACEUTICAL CO., LTD. v. MSN LABORATORIES PRIVATE LTD.

(1) The appeals are dismissed. (2) Each side shall bear its own costs.

FOR THE COURT

April 28, 2026 Date

ISSUED AS A MANDATE: April 28, 2026

Case-law data current through December 31, 2025. Source: CourtListener bulk data.